AdvanSix (ASIX) Scheduled to Post Earnings on Friday

AdvanSix (NYSE:ASIX) will release its earnings data before the market opens on Friday, May 3rd. Analysts expect AdvanSix to post earnings of ($0.66) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

AdvanSix (NYSE:ASIX) last issued its quarterly earnings results on Friday, February 16th. The company reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.19) by $0.02. The company had revenue of $382.21 million during the quarter, compared to analyst estimates of $335.80 million. AdvanSix had a net margin of 3.56% and a return on equity of 6.98%. On average, analysts expect AdvanSix to post $1 EPS for the current fiscal year and $4 EPS for the next fiscal year.

AdvanSix Stock Up 0.9 %

NYSE:ASIX opened at $25.49 on Thursday. The firm has a market cap of $683.39 million, a P/E ratio of 13.42 and a beta of 1.73. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.58 and a current ratio of 1.17. AdvanSix has a fifty-two week low of $23.92 and a fifty-two week high of $40.85. The firm has a 50-day simple moving average of $27.10 and a two-hundred day simple moving average of $27.15.

AdvanSix Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 18th. Shareholders of record on Monday, March 4th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, March 1st. This represents a $0.64 dividend on an annualized basis and a yield of 2.51%. AdvanSix’s dividend payout ratio is currently 33.68%.

Insider Buying and Selling at AdvanSix

In other AdvanSix news, CEO Erin N. Kane sold 5,000 shares of the firm’s stock in a transaction dated Thursday, March 28th. The shares were sold at an average price of $28.30, for a total transaction of $141,500.00. Following the completion of the sale, the chief executive officer now directly owns 557,755 shares in the company, valued at approximately $15,784,466.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, CEO Erin N. Kane sold 5,000 shares of AdvanSix stock in a transaction that occurred on Thursday, March 28th. The shares were sold at an average price of $28.30, for a total value of $141,500.00. Following the completion of the sale, the chief executive officer now directly owns 557,755 shares in the company, valued at $15,784,466.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Achilles B. Kintiroglou sold 4,000 shares of AdvanSix stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $27.69, for a total transaction of $110,760.00. Following the completion of the sale, the senior vice president now owns 38,996 shares of the company’s stock, valued at $1,079,799.24. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,387 shares of company stock worth $486,481. 5.20% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Separately, Stifel Nicolaus restated a “buy” rating and set a $40.00 price objective on shares of AdvanSix in a research note on Tuesday, April 9th.

About AdvanSix

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.